Dual regulation of Snail by GSK-3β-mediated phosphorylation in control of epithelial-mesenchymal transition

Nature Cell Biology

Volumn 6, Issue 10, 2004, Pages 931-940

  Zhou, Binhua P ^a   Deng, Jiong ^a   Xia, Weiya ^a   Xu, Jihong ^a   Li, Yan M ^a   Gunduz, Mehmet ^a   Hung, Mien Chie ^a  

^a UNIVERSITY OF TEXAS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCOGEN SYNTHASE KINASE 3BETA; TRANSCRIPTION FACTOR; UVOMORULIN; ZINC FINGER PROTEIN;

ARTICLE; CANCER CELL; CANCER INVASION; CELL MOTILITY; CELL NUCLEUS; CELL TRANSFORMATION; CELLULAR DISTRIBUTION; CONTROLLED STUDY; DOWN REGULATION; EMBRYO DEVELOPMENT; EPITHELIUM CELL; GENE EXPRESSION REGULATION; HALF LIFE TIME; HUMAN; HUMAN CELL; IN VIVO STUDY; MESENCHYME CELL; PHENOTYPE; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN MOTIF; PROTEIN PHOSPHORYLATION; PROTEIN STABILITY; PROTEIN VARIANT; REGULATORY MECHANISM; SIGNAL TRANSDUCTION; UBIQUITINATION; UPREGULATION;

AMINO ACID MOTIFS; BINDING SITES; BREAST NEOPLASMS; CADHERINS; CELL LINE, TUMOR; CELL NUCLEUS; CONSENSUS SEQUENCE; CYSTEINE ENDOPEPTIDASES; DNA-BINDING PROTEINS; ENZYME INHIBITORS; EPITHELIAL CELLS; GENE EXPRESSION REGULATION, NEOPLASTIC; GLYCOGEN SYNTHASE KINASE 3; HUMANS; LEUPEPTINS; LITHIUM; MESODERM; MULTIENZYME COMPLEXES; MUTATION; PHOSPHORYLATION; PROTEASOME ENDOPEPTIDASE COMPLEX; PROTEIN BINDING; SUBSTRATE SPECIFICITY; TRANSCRIPTION FACTORS; ZINC FINGERS;

GASTROPODA;

EID: 5444269904     PISSN: 14657392     EISSN: None     Source Type: Journal    
DOI: 10.1038/ncb1173     Document Type: Article

References (42)

1. Thiery, J. P. Epithelial-mesenchymal transitions in tumour progression. Nature Rev. Cancer 2, 442-454 (2002).
2. Nieto, M. A. The snail superfamily of zinc-finger transcription factors. Nature Rev Mol. Cell Biol. 3, 155-166 (2002).
3. Behrens, J., Lowrick, O., Klein-Hitpass, L. & Birchmeier, W. The E-cadherin promoter: functional analysis of a G-C-rich region and an epithelial cell-specific palindromic regulatory element. Proc. Natl Acad. Sci. USA 88, 11495-11499 (1991).
4. Birchmeier, W., Behrens, J., Weidner, K. M., Frixen, U. H. & Schipper, J. Dominant and recessive genes involved in tumor cell invasion. Curr. Opin. Cell Biol. 3, 832-840 (1991).
5. Hajra, K. M., Ji, X. & Fearon, E. R. Extinction of E-cadherin expression in breast cancer via a dominant repression pathway acting on proximal promoter elements. Oncogene 18, 7274-7279 (1999).
6. Ji, X., Woodard, A. S., Rimm, D. L. & Fearon, E. R. Transcriptional defects underlie loss of E-cadherin expression in breast cancer. Cell Growth Differ. 8, 773-778 (1997).
7. Giroldi, L. A. et al. Role of E boxes in the repression of E-cadherin expression. Biochem. Biophys. Res. Commun. 241, 453-458 (1997).
8. Batlle, E. et al. The transcription factor snail is a repressor of E-cadherin gene expression in epithelial tumour cells. Nature Cell Biol. 2, 84-89 (2000).
9. Guaita, S. et al. Snail induction of epithelia-to-mesenchymal transition in tumor cells is accompanied by MUC1 repression and ZEB1 expression. J. Biol. Chem. 277, 39209-39216 (2002).
10. Cano, A. et al. The transcription factor snail controls epithelial-mesenchymal transitions by repressing E-cadherin expression. Nature Cell Biol. 2, 76-83 (2000).
11. Comijn, J. et al. The two-handed E-box-binding zinc-finger protein SIP1 downregulates E-cadherin and induces invasion. Mol. Cell 7, 1267-1278 (2001).
12. Bolos, V. et al. The transcription factor Slug represses E-cadherin expression and induces epithelial-to-mesenchymal transitions: a comparison with Snail and E47 repressors. J Cell Sci. 116, 499-511 (2003).
13. Fujita, N. et al. MTA3, a Mi-2/NuRD complex subunit, regulates an invasive growth pathway in breast cancer. Cell 113, 207-219 (2003).
14. Peinado, H., Quintanilla, M. & Cano, A. Transforming growth factor β-1 induces snail transcription factor in epithelial cell lines: mechanisms for epithelial mesenchymal transitions. J. Biol. Chem. 278, 21113-21123 (2003).
15. Doble, B. W. & Woodgett, J. R. GSK-3: tricks of the trade for a multi-tasking kinase. J. Cell Sci. 116, 1175-1186 (2003).
16. Kim, L. & Kimmel, A. R. GSK3, a master switch regulating cell-fate specification and tumorigenesis. Curr. Opin. Genet. Dev. 10, 508-514 (2000).
17. Harwood, A. J. Regulation of GSK-3: a cellular multiprocessor. Cell 105, 821-824 (2001).
18. Cohen, P. & Frame, S. The renaissance of GSK3. Nature Rev. Mol. Cell Biol. 2, 769-776 (2001).
19. Muratani, M. & Tansey, W. P. How the ubiquitin-proteasome system controls transcription. Nature Rev. Mol. Cell Biol. 4, 192-201 (2003).
20. Stambolic, V., Ruel, L. & Woodgett, J. R. Lithium inhibits glycogen synthase kinase-3 activity and mimics wingless signalling in intact cells. Curr. Biol. 6, 1664-1668 (1996).
21. Fodde, R., Smits, R. & Clevers, H. APC, signal transduction and genetic instability in colorectal cancer. Nature Rev. Cancer 1, 55-67 (2001).
22. Karin, M., Cao, Y., Greten, F. R. & Li, Z. W. NF-κB in cancer: from innocent bystander to major culprit. Nature Rev. Cancer 2, 301-310 (2002).
23. Margottin-Goguet, F. et al. Prophase destruction of Emi1 by the SCF(βTrCP/Slimb) ubiquitin ligase activates the anaphase promoting complex to allow progression beyond prometaphase. Dev. Cell 4, 813-826 (2003).
24. Guardavaccaro, D. et al. Control of meiotic and mitotic progression by the F-box protein β-Trcp1 in vivo. Dev. Cell 4, 799-812 (2003).
25. Dominguez, D. et al. Phosphorylation regulates the subcellular location and activity of the snail transcriptional repressor. Mol. Cell. Biol. 23, 5078-5089 (2003).
26. Blanco, M. J. et al. Correlation of Snail expression with histological grade and lymph node status in breast carcinomas. Oncogene 21, 3241-3246 (2002).
27. Cheng, C. W. et al. Mechanisms of inactivation of E-cadherin in breast carcinoma: modification of the two-hit hypothesis of tumor suppressor gene. Oncogene 20, 3814-3823 (2001).
28. Rosivatz, E. et al. Differential expression of the epithelial-mesenchymal transition regulators snail, SIP1, and twist in gastric cancer. Am. J. Pathol. 161, 1881-1891 (2002).
29. Sugimachi, K. et al. Transcriptional repressor snail and progression of human hepatocellular carcinoma. Clin. Cancer Res. 9, 2657-2664 (2003).
30. Thiery, J. P. Epithelial-mesenchymal transitions in development and pathologies. Curr. Opin. Cell Biol. 15, 740-746 (2003).
31. Bijur, G. N. & Jope, R. S. Glycogen synthase kinase-3β is highly activated in nuclei and mitochondria. Neuroreport 14, 2415-2419 (2003).
32. Beals, C. R., Sheridan, C. M., Turck, C. W., Gardner, P. & Crabtree, G. R. Nuclear export of NF-ATc enhanced by glycogen synthase kinase-3. Science 275, 1930-1934 (1997).
33. Liu, C. et al. Control of β-catenin phosphorylation/degradation by a dual-kinase mechanism. Cell 108, 837-847 (2002).
34. Grille, S. J. et al. The protein kinase Akt induces epithelial-mesenchymal transition and promotes enhanced motility and invasiveness of squamous cell carcinoma lines. Cancer Res. 63, 2172-2178 (2003).
35. Kim, K., Pang, K. M., Evans, M. & Hay, E. D. Overexpression of β-catenin induces apoptosis independent of its transactivation function with LEF-1 or the involvement of major G1 cell cycle regulators. Mol. Biol. Cell 11, 3509-3523 (2000).
36. Zhou, B. P. et al. Cytoplasmic localization of p21Cip1/WAF1 by Akt-induced phosphorylation in HER-2/neu-overexpressing cells. Nature Cell Biol. 3, 245-252 (2001).
37. Zhou, B. P. et al. HER-2/neu induces p53 ubiquitination via Akt-mediated MDM2 phosphorylation. Nature Cell Biol. 3, 973-982 (2001).
38. Deng, J. et al. β-catenin interacts with and inhibits NF-κB in human colon and breast cancer. Cancer Cell 2, 323-334 (2002).
39. Zhou, B. P. et al. HER-2/neu blocks tumor necrosis factor-induced apoptosis via the Akt/NF-κB pathway. J. Biol. Chem. 275, 8027-8031 (2000).
40. Camp, R. L., Rimm, E. B. & Rimm, D. L. Met expression is associated with poor outcome in patients with axillary lymph node negative breast carcinoma. Cancer 86, 2259-2265 (1999).
41. Xia, W. et al. Phosphorylation/cytoplasmic localization of p21Cip1/WAF1 is associated with HER2/neu overexpression and provides a novel combination predictor for poor prognosis in breast cancer patients. Clin. Cancer Res. 10, 3815-3824 (2004).
42. Gunduz, M. et al. Genomic structure of the human ING1 gene and tumor-specific mutations detected in head and neck squamous cell carcinomas. Cancer Res. 60, 3143-3146 (2000).